propagermanium has been researched along with Insulin Resistance in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kleemann, R; Mulder, P; van den Hoek, AM | 1 |
| Akamizu, T; Arai, H; Ariyasu, H; Kanamori, H; Kita, T; Murayama, T; Ono, K; Sugimoto, M; Tamura, Y; Ueda, Y; Yokode, M | 1 |
| Akamizu, T; Arai, H; Ariyasu, H; Kita, T; Minami, M; Murayama, T; Nishikaze, Y; Sugimoto, M; Tamura, Y; Yokode, M | 1 |
3 other study(ies) available for propagermanium and Insulin Resistance
| Article | Year |
|---|---|
The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis.
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents; Arginase; CD11 Antigens; Chemokine CCL2; Diet, High-Fat; Germanium; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Organometallic Compounds; Propionates; Receptors, CCR2 | 2017 |
Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice.
Topics: Adipose Tissue; Adiposity; Animals; Cell Size; Fatty Liver; Germanium; Insulin Resistance; Liver; Macrophages; Male; Metabolic Syndrome; Mice; Mice, Mutant Strains; Mice, Obese; Obesity; Organometallic Compounds; Propionates; Receptors, CCR2; Triglycerides; Weight Gain | 2008 |
C-C chemokine receptor 2 inhibitor improves diet-induced development of insulin resistance and hepatic steatosis in mice.
Topics: Adipose Tissue; Animal Feed; Animals; Body Weight; Fatty Liver; Germanium; Inflammation; Insulin Resistance; Lipids; Male; Mice; Mice, Inbred C57BL; Obesity; Organometallic Compounds; Propionates; Receptors, CCR2; Tumor Necrosis Factor-alpha | 2010 |